Abstracts tagged "outcome measures and systemic lupus erythematosus (SLE)"

Abstract Number: 1411 • 2012 ACR/ARHP Annual Meeting
Equivalence of Various Language Versions of Lupus Specific Patient Reported Outcomes Measure (LupusPRO)
Meenakshi Jolly¹, Mark Kosinski², Sergio M.A. Toloza³, Joel A. Block⁴, Rachel A. Mikolaitis⁴, Sergio Durán-Barragan⁵, Ana M. Bertoli⁶, Ivana Blazevic⁷, Luis M. Vila⁸, Dilrukshie Cooray⁹, Emmanuel P. Katsaros¹⁰, Karina Marianne D. Torralba¹¹, Ioana Moldovan¹², Arif Kaya¹³, Berna Goker¹³, Seminur Haznedaroglu¹⁴, Mehmet E. Tezcan¹³, Josiane Bourré-Tessier¹⁵, Sasha Bernatsky¹⁶, Ann E. Clarke¹⁷, Michael H. Weisman¹⁸, Sandra V. Navarra¹⁹, Daniel J. Wallace²⁰ and Graciela S. Alarcon²¹, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²QualityMetric Inc, Lincoln, RI, ³Medicine, Hospital San Juan Bautista, Catamarca, Argentina, ⁴Section of Rheumatology, Rush University Medical Center, Chicago, IL, ⁵Unidad de Investigacion en Enfermedades Cronico-Degenerativas, Guadalajara, Mexico, ⁶Instituto Reumatológico Strusberg, Cordoba, Cordoba, Argentina, ⁷University of Buenos Aires, Buenos Aries, Argentina, ⁸Department of Medicine, Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, San Juan, PR, ⁹Rheumatology, Harbor UCLA Medical Center, Torrance, CA, ¹⁰Int Medicine, Loma Linda Univ, Loma Linda, CA, ¹¹Rheumatology/Int Med, USC Keck Schl of Medicine, Los Angeles, CA, ¹²Loma Linda Univ Medical Center, Loma Linda, CA, ¹³Internal Medicine-Rheumatology, Gazi University Medical School, Ankara, Turkey, ¹⁴Internal Medicine-Rheumatology, Gazi University School of Medicine, Ankara, Turkey, ¹⁵Rheumatology, McGill University, Montréal, QC, Canada, ¹⁶Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada, ¹⁷Division of Rheumatology, University of Calgary, Alberta, Calgary, AB, Canada, ¹⁸Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, ¹⁹University of Santo Tomas Hospital, Manila, Philippines, ²⁰Cedars-Sinai Medical Center, Los Angeles, CA, ²¹Medicine, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Due to observed disparities in health outcomes in Systemic Lupus Erythematosus (SLE) across racial/ethnic groups, socioeconomic status, or health care systems, studies on group…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].